IBRX logo

ImmunityBio (IBRX) Company Overview

Profile

Full Name:

ImmunityBio, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

July 28, 2015

Indexes:

Not included

Description:

ImmunityBio (IBRX) is a biotechnology company focused on developing innovative immunotherapies to treat cancer and infectious diseases. They aim to enhance the immune system's ability to fight diseases using advanced technologies, including cell therapy and vaccines, to improve patient outcomes and overall health.

Events Calendar

Earnings

Next earnings date:

May 9, 2025

Recent quarterly earnings:

Nov 12, 2024

Recent annual earnings:

N/A
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Jan 30, 25 D. Boral Capital
Buy
Jan 27, 25 D. Boral Capital
Buy
Jan 16, 25 D. Boral Capital
Buy
Jan 10, 25 BTIG
Buy
Jan 6, 25 D. Boral Capital
Buy
Dec 20, 24 D. Boral Capital
Buy
Nov 21, 24 D. Boral Capital
Buy
Nov 19, 24 D. Boral Capital
Buy
Nov 12, 24 D. Boral Capital
Buy
Oct 23, 24 EF Hutton
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for ImmunityBio?
  • Does ImmunityBio pay dividends?
  • What sector is ImmunityBio in?
  • What industry is ImmunityBio in?
  • What country is ImmunityBio based in?
  • When did ImmunityBio go public?
  • Is ImmunityBio in the S&P 500?
  • Is ImmunityBio in the NASDAQ 100?
  • Is ImmunityBio in the Dow Jones?
  • When was ImmunityBio's last earnings report?
  • When does ImmunityBio report earnings?
  • Should I buy ImmunityBio stock now?

What is the ticker symbol for ImmunityBio?

The ticker symbol for ImmunityBio is NASDAQ:IBRX

Does ImmunityBio pay dividends?

No, ImmunityBio does not pay dividends

What sector is ImmunityBio in?

ImmunityBio is in the Healthcare sector

What industry is ImmunityBio in?

ImmunityBio is in the Biotechnology industry

What country is ImmunityBio based in?

ImmunityBio is headquartered in United States

When did ImmunityBio go public?

ImmunityBio's initial public offering (IPO) was on July 28, 2015

Is ImmunityBio in the S&P 500?

No, ImmunityBio is not included in the S&P 500 index

Is ImmunityBio in the NASDAQ 100?

No, ImmunityBio is not included in the NASDAQ 100 index

Is ImmunityBio in the Dow Jones?

No, ImmunityBio is not included in the Dow Jones index

When was ImmunityBio's last earnings report?

ImmunityBio's most recent earnings report was on Nov 12, 2024

When does ImmunityBio report earnings?

The next expected earnings date for ImmunityBio is May 9, 2025

Should I buy ImmunityBio stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions